Home etftrends.com Marijuana ETFs Jump as Tilray Secures Distribution in the U.K.

Marijuana ETFs Jump as Tilray Secures Distribution in the U.K.

Marijuana stocks and cannabis-related exchange traded funds climbed Tuesday after Tilray (NasdaqGS: TLRY) struck a deal with Grow Pharma to import and distribute medical cannabis products in the United Kingdom, potentially foreshadowing the expansion of the pot businesses into more globalized markets.

Among the best performing non-leveraged ETFs of Tuesday, the ETFMG Alternative Harvest ETF (NYSEArca: MJ)advanced 13.4%, Cambria Cannabis ETF (TOKE) increased 9.4%, Global X Cannabis ETF (NASDAQ: POTX) surged 17.2%, AdvisorShares Pure Cannabis ETF (YOLO) gained 6.1%, Amplify Seymour Cannabis ETF (NYSEARCA: CNBS) rose 11.4%, and The Cannabis ETF (NYSE ARCA: THCX) jumped 14.5%.

Meanwhile, Tilray shares rallied over 40% on Tuesday.

TLRY 1 Year Performance

As part of the new partnership, Tilray will be able to provide medical marijuana products to U.K. patients with prescriptions obtained through the country’s National Health Service or a private-practice doctor, CNBC reports.

“This partnership with Grow Pharma provides patients in need access to a sustained supply of GMP-certified, high-quality medical cannabis and is an important step in improving access in the UK,” Tilray CEO Brendan Kennedy said in a statement.

Grow Pharma CEO Pierre van Weperen believed the new agreement provides U.K. patients with “a secure and sustainable supply of the highest-quality medical cannabis products.”

The deal is the latest from Tilray to expand its market share in the global cannabis segment. Tilray recently stated its plans to merge with Aphria. The deal will create the largest cannabis company in the world once finalized.

For more news, information, and strategy, visit the Equity ETF Channel.

newETFs.io respects the hard work of others and gives all credit to the remarkable folks at ETFTrends.com. This excerpt/article was pulled from their RSS feed; click here to view the original. Please note that on occasion, the RSS feed will not have the author. When this happens this site defaults the author to "News". Make no mistake, this excerpt/article was not created by newETFs.io, it was simply shared with you.